ArticleJournal of robotic surgery2026
Comparative outcomes and adoption trends of robotic versus non-robotic ureteral reconstruction: a national matched cohort study.
Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The adoption of robotic platforms for ureteral reconstruction has grown considerably over the past decade, yet rigorous comparative data evaluating perioperative safety and longitudinal outcomes relative to non-robotic approaches remain scarce. This study sought to characterize national trends in robotic utilization and compare outcomes between robotic and non-robotic ureteral reconstruction using a propensity-matched national cohort. Adult patients undergoing ureteral reconstruction between 2014 and 2024 were identified within the TriNetX Research Network. Robotic procedures were distinguished using the S2900 billing modifier. Following 1:1 propensity score matching for demographics and key comorbidities, 2,787 patients were included per cohort. Intraoperative, immediate postoperative, 30-day, and two-year outcomes were compared between groups, and annual procedural proportions were analyzed to quantify adoption trends. Robotic ureteral reconstruction rose from 5.8% of all procedures in 2014 to 23.1% by 2024. Compared with non-robotic repair, robotic cases had lower rates of bowel injury (1.2% vs. 2.7%; OR 0.45, p < 0.001), vascular injury (0.5% vs. 2.0%; OR 0.23, p < 0.001), blood transfusion (1.4% vs. 5.0%; OR 0.27, p < 0.001), postoperative ileus (0.6% vs. 1.3%; OR 0.47, p = 0.009), and 30-day readmission (7.9% vs. 12.1%; OR 0.62, p < 0.001). Infection, sepsis, and stent placement rates were comparable. At two years, repeat ureteral procedures and chronic kidney disease rates were similar between groups. Robotic ureteral reconstruction is associated with meaningful reductions in perioperative morbidity while preserving long-term reconstructive outcomes equivalent to non-robotic repair. The decade-long rise in robotic adoption reflects an expanding evidence base supporting its role in complex ureteral disease.
Indexed as
Identifiers
42329334What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.